Xiaoping Qi

Xiaoping Qi is a Senior Director of Regulatory Affairs at Alumis, where they currently hold a leadership position. Previously, they garnered extensive experience in regulatory affairs and clinical virology at Gilead Sciences, progressing through multiple roles including Associate Scientist and culminating as Associate Director. Xiaoping also served as Director of Regulatory Affairs at Myovant Sciences from 2020 to 2023 and began their career as a Research Scientist at Bristol Myers Squibb. They are pursuing a Master of Science in Biochemistry at the University of Notre Dame and hold a Bachelor of Science in Biochemistry from East China University of Science and Technology.